PCSK9 immunization using nanoliposomes: preventive efficacy against hypercholesterolemia and atherosclerosis

CONCLUSIONS: L-IFPTA+ vaccine can induce long-lasting, functional and safe PCSK9-specific antibodies in hypercholesterolemic C57BL/6 mice, providing a long-term protective impact on dyslipidemia and atherosclerosis.PMID:34522266 | PMC:PMC8425258 | DOI:10.5114/aoms/133885

Source: Archives of Medical Science - September 15, 2021 Category: General Medicine Authors: Amir Abbas Momtazi-Borojeni Mahmoud Reza Jaafari Mohammad Afshar Maciej Banach Amirhossein Sahebkar Source Type: research